Application and contribution of animal models in drug bioavailability
Cabana, B.E.
Psychopharmacology Bulletin 12(4): 51-54
1976
ISSN/ISBN: 0048-5764 PMID: 972990 Document Number: 100364
Document emailed within 1 workday
Related Documents
Morley-Fletcher, S.; Rea, M.; Adriani, W.; Laviola, G. 2001: Impact of socio-environmental factors on physiological processes of brain damage recovery: contribution of animal models Annali Dell'istituto Superiore di Sanita 37(4): 567-572McMillan, D.E. 1977: Animal models of oral drug self-administration Psychopharmacology Bulletin 13(1): 38-39
Akin, F.J.; Rose, A.P.; Chamness, T.W.; Marlowe, E. 1979: Sunscreen protection against drug-induced phototoxicity in animal models Toxicology and Applied Pharmacology 49(2): 219-224
Leodolter, S. 1972: Intraperitoneal application of a triamcinolon-acetonide crystal suspension. An animal experiment designed as a contribution to the prevention of adhesion with corticosteroids Acta Europaea Fertilitatis 3(4): 339-346
Firsov, A.A.; Piotrovskii, V.K. 1986: Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability Die Pharmazie 41(7): 457-465
Yanagihara, Y.; Abe, T.; Edanami, K.; Agata, M.; Kuroda, T.; Shida, T. 1988: Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models Arzneimittel-Forschung 38(1): 70-74
Mashiba, T.; Iwata, K.; Komatsubara, S.; Manabe, T. 2011: Animal models for bone and joint disease. Animal fracture model and fracture healing process Clinical Calcium 21(2): 235-241
1988: The Veterinary Service Board. Animal drug legislation. Packaging and labelling of animal drugs Tijdschrift Voor Diergeneeskunde 113(18): 1031-1032
Nagasawa, R.; Maruyama, N. 1988: Study of autoimmune diseases using animal disease models. 1) Molecular genetic analysis of autoimmune disease models Nihon Rinsho. Japanese Journal of Clinical Medicine 46(4): 845-849
Chunhabundit, R.; Srianujata, S.; Bunyaratvej, A.; Kongkachuichai, R.; Satayavivad, J.; Kaojarern, S. 2011: Cadmium bioavailability from vegetable and animal-based foods assessed with in vitro digestion/caco-2 cell model Journal of the Medical Association of Thailand 94(2): 164-171
Hau, T.; Simmons, R.L. 1977: Animal models of peritonitis Surgery Gynecology and Obstetrics 144(5): 755-756
Meyer, O. 1981: Animal models in lupus Revue du Rhumatisme et des Maladies Osteo-Articulaires 48(12): 817-825
Kusewitt, D.F.; Ley, R.D. 1996: Animal models of melanoma Cancer Surveys 26: 35-70
Date, M.; Otsu, K.; Kuzuya, T.; Hori, M. 2000: Animal models of cardiomyopathy Nihon Rinsho. Japanese Journal of Clinical Medicine 58(1): 233-239
Rabin, H.R.; Urtasun, R.C.; Partington, J.; Koziol, D.; Sharon, M.; Walker, K. 1980: High-dose metronidazole: pharmacokinetics and bioavailability using an iv preparation and application of its use as a radiosensitizer Cancer Treatment Reports 64(10-11): 1087-1095
Jee, W.S.; Ma, Y. 1999: Animal models of immobilization osteopenia Morphologie: Bulletin de l'Association des Anatomistes 83(261): 25-34
Soubrie, P.; Chermat, R.; Poncelet, M.; Simon, P. 1978: Models of inhibition in animal behavior L'Encephale 4(5 Suppl): 503-511
Mendez, J.D.; Ramos, H.G. 1994: Animal models in diabetes research Archives of Medical Research 25(4): 367-375
Ursick, J.; Staecker, H. 2007: An overview of animal models of tinnitus B-Ent 3(Suppl 7): 23-25
Bhatnagar, A.; Majumdar, S. 2003: Animal models of hepatic encephalopathy Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 22(Suppl 2): S33-S36